The trajectory of Viagra, originally marketed by copyright, presents a intricate case study for backers considering the pharmaceutical sector. Although its initial success and creation of billions in revenue , the exclusivity end has opened the door for competing medications, significantly eroding earnings potential . This shift raises concerns abo